|
| 35027753 | Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. | Nat Med | 2022 |
| 34793719 | Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study. | Lancet Oncol | 2021 |
| 33514714 | Direct control of CAR T cells through small molecule-regulated antibodies. | Nat Commun | 2021 |
| 33256806 | Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity. | J Hematol Oncol | 2020 |
| 31257988 | Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα. | MAbs | 2019 |
| 29078037 | The effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2οa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies. | Cardiovasc Ther | 2018 |
| 30133535 | ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile. | PLoS One | 2018 |
| 29714014 | Epitope Mapping Using Yeast Display and Next Generation Sequencing. | Methods Mol Biol | 2018 |
| 29227213 | Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies. | MAbs | 2018 |
| 28151644 | Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates. | Bioconjug Chem | 2017 |
| 26944918 | Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design. | Mol Cancer Ther | 2016 |
| 26481561 | Production of soluble and active microbial transglutaminase in Escherichia coli for site-specific antibody drug conjugation. | Protein Sci | 2016 |
| 27582525 | RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models. | Mol Cancer Ther | 2016 |
| 27857134 | Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire. | Nat Commun | 2016 |
| 27129258 | Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain. | J Biol Chem | 2016 |
| 25284753 | Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencing. | J Mol Biol | 2015 |
| 26161543 | Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC Efficacy. | PLoS One | 2015 |
| 26154005 | Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading. | Nat Biotechnol | 2015 |
| 25658443 | The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity. | MAbs | 2015 |
| 25643134 | Effect of attachment site on stability of cleavable antibody drug conjugates. | Bioconjug Chem | 2015 |
| 24359082 | Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates. | Bioconjug Chem | 2014 |
| 24981332 | Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. | Cell Host Microbe | 2014 |
| 24830649 | Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes. | MAbs | 2014 |
| 24651868 | High-throughput epitope binning assays on label-free array-based biosensors can yield exquisite epitope discrimination that facilitates the selection of monoclonal antibodies with functional activity. | PLoS One | 2014 |
| 23228330 | Impact of mutations on the allosteric conformational equilibrium. | J Mol Biol | 2013 |
| 24223227 | Determining the binding affinity of therapeutic monoclonal antibodies towards their native unpurified antigens in human serum. | PLoS One | 2013 |
| 23630353 | The restricted DH gene reading frame usage in the expressed human antibody repertoire is selected based upon its amino acid content. | J Immunol | 2013 |
| 23416200 | Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. | J Mol Biol | 2013 |
| 23438745 | Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates. | Chem Biol | 2013 |
| 22197375 | Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease. | J Mol Biol | 2012 |
| 23093611 | A method for integrative structure determination of protein-protein complexes. | Bioinformatics | 2012 |
| 22543237 | Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair. | J Mol Biol | 2012 |
| 22558410 | Exploring the dynamic range of the kinetic exclusion assay in characterizing antigen-antibody interactions. | PLoS One | 2012 |
| 22609372 | Label-free epitope binning assays of monoclonal antibodies enable the identification of antigen heterogeneity. | J Immunol Methods | 2012 |
| 22294692 | Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9. | J Biol Chem | 2012 |
| 22403063 | Structure-based model of allostery predicts coupling between distant sites. | Proc Natl Acad Sci U S A | 2012 |
| 22019884 | Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates. | J Pharmacol Exp Ther | 2012 |
| 22045481 | 39-week toxicity and toxicokinetic study of ponezumab (PF-04360365) in cynomolgus monkeys with 12-week recovery period. | J Alzheimers Dis | 2012 |
| 21168382 | Expanding the ProteOn XPR36 biosensor into a 36-ligand array expedites protein interaction analysis. | Anal Biochem | 2011 |
| 22123975 | Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation. | Proc Natl Acad Sci U S A | 2011 |
| 21825149 | Phenotype-information-phenotype cycle for deconvolution of combinatorial antibody libraries selected against complex systems. | Proc Natl Acad Sci U S A | 2011 |
| 21787786 | Synthetic antibodies designed on natural sequence landscapes. | J Mol Biol | 2011 |
| 21690377 | Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. | Proc Natl Acad Sci U S A | 2011 |
| 19111520 | Exploring blocking assays using Octet, ProteOn, and Biacore biosensors. | Anal Biochem | 2009 |
| 19875695 | Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. | Proc Natl Acad Sci U S A | 2009 |
| 19369565 | Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 mice. | J Neurosci | 2009 |
| 18405656 | Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet. | Anal Biochem | 2008 |
| 18776916 | CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. | Br J Pharmacol | 2008 |
| 18505735 | Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors. | Protein Sci | 2008 |
| 18607758 | Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice. | J Neuroimmune Pharmacol | 2008 |